Rupert Haynes and Raza Bokhari, with FSD Pharma discuss the company’s pharma initiative, synthetic cannabinoids and extraction methods.
The post FSD Pharma Strengthens Drug Development With GW Executive appeared first on Investing News Network.
Original Article: FSD Pharma Strengthens Drug Development With GW Executive